200 related articles for article (PubMed ID: 16199099)
1. Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril.
Ledford RM; Collett MS; Pevear DC
Antiviral Res; 2005 Dec; 68(3):135-8. PubMed ID: 16199099
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
3. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
[TBL] [Abstract][Full Text] [Related]
4. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants.
Groarke JM; Pevear DC
J Infect Dis; 1999 Jun; 179(6):1538-41. PubMed ID: 10228078
[TBL] [Abstract][Full Text] [Related]
5. Phylogenetic relationships and molecular adaptation dynamics of human rhinoviruses.
Lewis-Rogers N; Bendall ML; Crandall KA
Mol Biol Evol; 2009 May; 26(5):969-81. PubMed ID: 19182223
[TBL] [Abstract][Full Text] [Related]
6. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
7. A novel benzonitrile analogue inhibits rhinovirus replication.
Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
[TBL] [Abstract][Full Text] [Related]
8. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
[TBL] [Abstract][Full Text] [Related]
9. Proposals for the classification of human rhinovirus species C into genotypically assigned types.
Simmonds P; McIntyre C; Savolainen-Kopra C; Tapparel C; Mackay IM; Hovi T
J Gen Virol; 2010 Oct; 91(Pt 10):2409-19. PubMed ID: 20610666
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide diversity and selective pressure in the human rhinovirus.
Kistler AL; Webster DR; Rouskin S; Magrini V; Credle JJ; Schnurr DP; Boushey HA; Mardis ER; Li H; DeRisi JL
Virol J; 2007 May; 4():40. PubMed ID: 17477878
[TBL] [Abstract][Full Text] [Related]
11. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses.
Pevear DC; Hayden FG; Demenczuk TM; Barone LR; McKinlay MA; Collett MS
Antimicrob Agents Chemother; 2005 Nov; 49(11):4492-9. PubMed ID: 16251287
[TBL] [Abstract][Full Text] [Related]
12. New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features.
Tapparel C; Junier T; Gerlach D; Cordey S; Van Belle S; Perrin L; Zdobnov EM; Kaiser L
BMC Genomics; 2007 Jul; 8():224. PubMed ID: 17623054
[TBL] [Abstract][Full Text] [Related]
13. Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance.
Basta HA; Ashraf S; Sgro JY; Bochkov YA; Gern JE; Palmenberg AC
Virology; 2014 Jan; 448():82-90. PubMed ID: 24314639
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses.
Kaiser L; Crump CE; Hayden FG
Antiviral Res; 2000 Sep; 47(3):215-20. PubMed ID: 10974374
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses.
Lacroix C; Laconi S; Angius F; Coluccia A; Silvestri R; Pompei R; Neyts J; Leyssen P
Virol J; 2015 Jul; 12():106. PubMed ID: 26169596
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket.
Braun H; Kirchmair J; Williamson MJ; Makarov VA; Riabova OB; Glen RC; Sauerbrei A; Schmidtke M
Antiviral Res; 2015 Nov; 123():138-45. PubMed ID: 26391975
[TBL] [Abstract][Full Text] [Related]
18. New class of early-stage enterovirus inhibitors with a novel mechanism of action.
Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C
Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161
[TBL] [Abstract][Full Text] [Related]
19. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
[TBL] [Abstract][Full Text] [Related]
20. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
